Intellectia LogoIntellectia
Product
Resources
Stock
Crypto
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategy
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns

Resources

Learn
Blog
Earnings
Tutorial
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
StockCryptoPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. UPB
    4. >
  4. Forecast

Stock Price Prediction

-
stocks logo
UPB
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

UPB Similar Chart Price Prediction

The price of UPB is predicted to go up -6.74%, based on the high correlation periods with ATXI. The similarity of these two price pattern on the periods is 97.84%.

stocks logo

UPB

stocks logo

ATXI

Down: -6.74%Similarity: 97.84%

UPB Revenue Forecast

UPB EPS Forecast

UPB FAQs

What is bull’s view on UPB?

UPB stock has a bullish outlook with a price target of $75 set by Piper Sandler, reflecting a 173.82% upside. Analysts highlight the potential of its lead drug, verekitug, which shows superior efficacy and dosing advantages in treating asthma. Additionally, the company’s strong financial position post-IPO supports its ongoing clinical trials and long-term growth.

What is bear's view on UPB?

UPB stock currently faces bearish sentiment due to its high R&D expenses, resulting in a Q3 2024 net loss of $16 million, despite a strong cash position of $220.7 million. The stock's recent IPO priced at $17 per share has seen limited upside, with concerns over its early-stage pipeline and long-term profitability. Without significant positive trial results or partnerships, the stock may struggle to sustain above $15 in the near term.

What is UPB revenue forecast for next quarter？

The market consensus for UPB's revenue in the upcoming quarter is projected to be approximately $400K USD.

What is UPB eps forecast for next quarter？

The market consensus for UPB's eps in the upcoming quarter is projected to be approximately $0.49 USD.

UPB VS S&P500

Ask Intellectia about UPB

UPB Analyst's Forecast

Tessa Romero

JP Morgan

Buy

2024-11-05

Price Target

$38

Upside

+38.74%

JPMorgan initiated coverage of Upstream Bio with an Overweight rating and $38 price target. Upsteam's lead asset is verekitug, a recombinant human IgG1 monoclonal antibody that binds the thymic stromal lymphopoietin receptor to treat severe asthma, chronic rhinosinusinitis with nasal polyps and COPD, the analyst tells investors in a research note. The firm sees verekitug as the sole driver for shares over the mid to long term as the clinical profile matures.
Matt Phipps

William Blair

Buy

2024-11-05

Price Target

n/a

Downside

0%

Yaron Werber

TD Cowen

Strong Buy

2024-11-05

Price Target

n/a

Downside

0%

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI Screener
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free

Hot Stocks

stocks logo

KMPR

Kemper Corp

$64.8
-1.47%
stocks logo

KGS

Kodiak Gas Services Inc

$43.02
2.36%
stocks logo

FLO

Flowers Foods Inc

$18.89
-2.28%
stocks logo

ASB

Associated Banc-Corp

$24.2
0.04%
stocks logo

GBDC

Golub Capital Bdc Inc

$15.69
0.00%
stocks logo

AI

C3.ai Inc

$26.52
0.72%
stocks logo

IBOC

International Bancshares Corp

$65.2
-0.56%
stocks logo

GVA

Granite Construction Inc

$82.955
1.29%
stocks logo

PRCT

Procept Biorobotics Corp

$68.54
9.30%
stocks logo

CRGY

Crescent Energy Co

$13.395
-2.15%